Introduction to the Requirements for Haemopoietic Cellular Therapy
This guidance has been developed to help consumers understand and navigate the draft Requirements for Haemopoietic Cellular Therapy (HCT Standard) which is currently out for consultation.
This guidance explains the key components of the HCT Standard and how it supports the safe and high-quality delivery of haemopoietic cellular therapy. It outlines the requirements that help ensure cellular therapy products are:
- safely collected from a patient or an appropriate donor
- carefully processed, stored and transported to maintain quality and integrity
- administered to patients through safe and high-quality clinical practices.
By setting consistent national requirements, the HCT Standard helps promote patient safety, quality care and confidence in haemopoietic cellular therapy services across Australia.
Downloads
Introduction to the Requirements for Haemopoietic Cellular Therapy
- For more information:
- Requirements for Haemopoietic Cellular Therapy
- Publication Year:
- 2026
- Resource Type:
- Guide, user guide or guidelines
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.